Nonprofit · EIN 20-4773370
THE INTERNATIONAL THYROID CANCER STUDY GROUP INC
Tax-exempt · YORKVILLE, NY 13495
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $613,818 | $372,508 | $241,310 | $4,950,358 | $45,995 | $4,904,363 |
| December 31, 2024 | 990 | $541,804 | $361,108 | $180,696 | $4,343,548 | $5,000 | $4,338,548 |
| December 31, 2023 | 990 | $379,506 | $211,213 | $168,293 | $4,087,622 | $5,000 | $4,082,622 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $390,289
- Program service revenue
- $0
- Investment income
- $223,529
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $76,370
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $0
- Program services (functional)
- $279,970
- Management and general (functional)
- $92,538
Balance sheet and other
- Total assets, start of year
- $4,343,548
- Total assets, end of year
- $4,950,358
- Total liabilities, end of year
- $45,995
- Net assets, end of year
- $4,904,363
- Publicly traded securities
- $3,627,620
- Net assets without donor restrictions
- $4,904,363
- Gross receipts
- $613,818
- Employees
- 0
- Volunteers
- 100
- Year formed
- 2006
- State of legal domicile
- DE
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DWIGHT VICKS III MBA | CFO/ CO-FOUNDER Trustee or director, Officer | 5 | $0 |
| LAURA FUGAZZOLA | DIRECTOR Trustee or director | 2 | $0 |
| CARMELLO NUCERA | DIRECTOR Trustee or director | 5 | $0 |
| NAIFA BUSAIDY MD | DIRECTOR Trustee or director | 2 | $0 |
| JULIE ANN SOSA MD | FINANCE CHAIR Trustee or director | 2 | $0 |
| ALAN HO MD PHD | CORRELATIVE CHAIR Trustee or director | 2 | $0 |
| GREGORY RANDOLPH MD | PRESIDENT Trustee or director, Officer | 2 | $0 |
| CHRISTINE SPITZWEG | DIRECTOR Trustee or director | 2 | $0 |
| LAURA BOUCAI MD | SECRETARY Trustee or director, Officer | 2 | $0 |
| FRANK WORDEN MD | PROTOCOL COMMITTE CHAIR Trustee or director | 2 | $0 |
| IAN GANLEY MD PHD | DIRECTOR Trustee or director | 2 | $0 |
| LINDSEY BISCHOFF MD | DIRECTOR Trustee or director | 2 | $0 |
| SARIMAR AGOSTO SALGADO MD | DIRECTOR Trustee or director | 2 | $0 |
| VICTOR BERNET MD | DIRECTOR Trustee or director | 2 | $0 |
990 for the year ended December 31, 2024: 14 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DWIGHT VICKS III MBA | CFO/ CO-FOUNDER Trustee or director, Officer | 5 | $0 |
| LAURA FUGAZZOLA | DIRECTOR Trustee or director | 2 | $0 |
| CARMELLO NUCERA | DIRECTOR Trustee or director | 5 | $0 |
| NAIFA BUSAIDY MD | DIRECTOR Trustee or director | 2 | $0 |
| JULIE ANN SOSA MD | FINANCE CHAIR Trustee or director | 2 | $0 |
| ALAN HO MD PHD | CORRELATIVE CHAIR Trustee or director | 2 | $0 |
| GREGORY RANDOLPH MD | PRESIDENT Trustee or director, Officer | 2 | $0 |
| CHRISTINE SPITZWEG | DIRECTOR Trustee or director | 2 | $0 |
| LAURA BOUCAI MD | SECRETARY Trustee or director, Officer | 2 | $0 |
| FRANK WORDEN MD | PROTOCOL COMMITTE CHAIR Trustee or director | 2 | $0 |
| IAN GANLEY MD PHD | DIRECTOR Trustee or director | 2 | $0 |
| LINDSEY BISCHOFF MD | DIRECTOR Trustee or director | 2 | $0 |
| SARIMAR AGOSTO SALGADO MD | DIRECTOR Trustee or director | 2 | $0 |
| VICTOR MERNET MD | DIRECTOR Trustee or director | 2 | $0 |
990 for the year ended December 31, 2023: 14 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DWIGHT VICKS III MBA | CFO/ CO-FOUNDER Trustee or director, Officer | 5 | $0 |
| LAURA FUGAZZOLA | DIRECTOR Trustee or director | 2 | $0 |
| CARMELLO NUCERA | DIRECTOR Trustee or director | 5 | $0 |
| NAIFA BUSAIDY MD | DIRECTOR Trustee or director | 2 | $0 |
| JULIE ANN SOSA MD | FINANCE CHAIR Trustee or director | 2 | $0 |
| ANDREW GIANOUKAKIS MD | MEMBER CHAIR Trustee or director | 5 | $0 |
| ALAN HO MD PHD | CORRELATIVE CHAIR Trustee or director | 2 | $0 |
| GREGORY RANDOLPH MD | PRESIDENT Trustee or director, Officer | 2 | $0 |
| WENDY SAX | DIRECTOR Trustee or director | 2 | $0 |
| MARK ZAFAREO | DIRECTOR Trustee or director | 2 | $0 |
| BYRAN HAUGEN | PROTOCOL CHAIR Trustee or director | 2 | $0 |
| MABEL RYDER | SECRETARY Trustee or director, Officer | 5 | $0 |
| KATE NEWBOLD | DIRECTOR Trustee or director | 2 | $0 |
| CHRISTINE SPITZWEG | DIRECTOR Trustee or director | 2 | $0 |
Address and contacts
- Address (IRS master file)
- 5166 COMMERCIAL DR, YORKVILLE, NY 13495-1109
- In care of
- % DWIGHT E VICKS III
- Principal officer (990 for 2025)
- DWIGHT VICKS III, 5166 COMMERCIAL DRIVE, YORKVILLE, NY 13495
- Signed the 990
- DWIGHT VICKS III, CFO
- Phone
- (315) 272-2455
- Website
- ITOG.ORG
- Return prepared by
- FITZGERALD DEPIETRO & WOJNAS CPAS PC
Mission
THE INTERNATIONAL THYROID ONCOLOGY GROUP HAS BEEN ORGANIZED AND WILL BE OPERATED EXCLUSIVELY TO SERVE THE EXEMPT PURPOSE OF (1) FURTHERING SCIENTIFIC RESEARCH INTO POSSIBLE CURES FOR THYROID CANCER; AND (2) EDUCATING THE PUBLIC REGARDING THYROID CANCER AND RESEARCH INTO POSSIBLE CURES FOR THE DISEASE BY HOSTING CONFERENCES, MEETINGS, AND OTHER EDUCATIONAL PROGRAMS, AND BY DISSEMINATING RESEARCH RESULTS REGARDING THYROID CANCER TREATMENTS.
Program accomplishments
- FURTHER THE STUDY AND DISSEMINATION OF KNOWLEDGE OF THYROID CANCER, DEVELOP, INITIATE AND PERFORM MULTI-CENTER, PROSPECTIVE CLINICAL TRIALS FOR ALL TYPES OF TREATMENTS OF THYROID CANCER, CONDUCT INNOVATIVE TRANSLATIONAL RESEARCH STUDIES BASED ON ITOG CLINICAL TRIALS, AND ENCOURAGE CRITICAL INQUIRY AND OPEN PUBLICATION OF RESEARCH RESULTS.Expenses $279,970 · grants $76,370
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 20-4773370
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2007
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H50)
- Assets (IRS master file)
- $4,950,358
- Income (IRS master file)
- $613,818
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $613,818 | $372,508 | $4,950,358 | XML |
| 990 | December 2024 | $541,804 | $361,108 | $4,343,548 | XML |
| 990 | December 2023 | $379,506 | $211,213 | $4,087,622 | XML |
| 990 | December 2022 | $420,403 | $167,566 | $3,731,345 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-4773370).
Questions about THE INTERNATIONAL THYROID CANCER STUDY GROUP INC
- What is the EIN of THE INTERNATIONAL THYROID CANCER STUDY GROUP INC?
- The employer identification number (EIN) of THE INTERNATIONAL THYROID CANCER STUDY GROUP INC is 20-4773370.
- Is THE INTERNATIONAL THYROID CANCER STUDY GROUP INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2007.
- Are donations to THE INTERNATIONAL THYROID CANCER STUDY GROUP INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does THE INTERNATIONAL THYROID CANCER STUDY GROUP INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of THE INTERNATIONAL THYROID CANCER STUDY GROUP INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did THE INTERNATIONAL THYROID CANCER STUDY GROUP INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of THE INTERNATIONAL THYROID CANCER STUDY GROUP INC?
- The 990 for the year ended December 31, 2025 names DWIGHT VICKS III.
- Who are the officers and directors of THE INTERNATIONAL THYROID CANCER STUDY GROUP INC?
- The 990 for the year ended December 31, 2025 lists 14 people; 0 received compensation from the organization.
- How much revenue does THE INTERNATIONAL THYROID CANCER STUDY GROUP INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $613,818, expenses of $372,508 and total assets of $4,950,358 at year end.
Other nonprofits in YORKVILLE
- NEW HOPE CHILDRENS MINISTRIES EIN 26-1812989 · last filed 990 for 2024
- DEPARTMENT OF NEW YORK VFW AUXILIARY EIN 86-1128494 · last filed 990-N for 2025
- WHITESTOWN POLICE BENEVOLENT ASSOCIATION INC EIN 47-1934194 · last filed 990-N for 2024
- ONEIDA COUNTY PRIDE ALLIANCE INC EIN 33-3182446 · last filed 990-N for 2025